BJP
BJP Laboratories, a leading Australian contract manufacturer of listed medicines, sold 80% of its shares to DZG Investments, the Australian subsidiary of the Goubuli Group, a Chinese food and beverage company.
Healthcare
![](https://www.clairfield.com/wp-content/uploads/2022/05/BJP.png)
Sale
![](https://www.clairfield.com/wp-content/uploads/2022/05/DZG-Investments-pty-ltd.jpg)
Advisor to the seller
Sectors :